Tech Company Financing Transactions
NeoMend Funding Round
Sanderling Ventures joined a $150 thousand funding round for NeoMend. The financing round was announced by the company on 3/31/2005.
Transaction Overview
Company Name
Announced On
3/31/2005
Transaction Type
Venture Equity
Amount
$150,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
60 Technology Drive
Irvine, CA 92618
USA
Irvine, CA 92618
USA
Phone
Website
Email Address
Overview
NeoMend, Inc. is a privately held, clinical stage biomedical device company engaged in the development and commercialization of advanced surgical wound healing products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Renzi
Chief Financial Officer
Kevin Cousins
VP - Marketing
Mike Nagel
VP - Operations
David Hanson
VP - R & D
Peter Davis
VP - Regulatory Affairs
Pamela Misajon
Browse more venture capital transactions:
Prev: 3/31/2005: NineSigma venture capital transaction
Next: 3/31/2005: IntelliDx venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC transactions reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs